MedTrace Logo

Inflammasomes in Cell Death in FTMH, ERM, and RRD

NCT03332758 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 41

Last updated 2018-08-17

No results posted yet for this study

Summary

Prospective study evaluating the role of inflammasomes in cell death in retinal detachment, full thickness macular hole, and epiretinal membrane. The investigators are collecting vitreous and subretinal fluid samples from patients with these conditions and evaluating activity of the inflammasome pathway with established assays.

Conditions

  • Retinal Detachment
  • Full Thickness Macular Hole
  • Epiretinal Membrane

Interventions

PROCEDURE

Pars plana vitrectomy

Standard of care treatment for retinal detachment, macular hole, or epiretinal membrane.

PROCEDURE

External drainage

Standard of care treatment for retinal detachment.

Sponsors & Collaborators

  • Mid Atlantic Retina

    collaborator OTHER

  • Allen C. Ho, MD

    lead OTHER

Principal Investigators

  • Allen C Ho, MD · MidAtlantic Retina

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-08
Primary Completion
2018-04-10
Completion
2018-05-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03332758 on ClinicalTrials.gov